Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology
Authors' conclusion
The vast majority of participants, among which elderly and patients with rheumatic diseases, were able to successfully draw the required amount of blood for serological analyses.
Study context
- Population
- Patients with rheumatic diseases and healthy controls in a digital COVID-19 research platform performing home finger-prick testing
- Participants
- 2,135 vs 899
- Exposure
- Patients with rheumatic diseases vs healthy controls
- Patientsn = 2,135
- Controlsn = 899reference
- Outcome
- Success rate of the finger prick and patients' perspective towards the finger prick
Methodological detailsdigital research platform, longitudinal, remote home finger-prick testing, Serum samples collected up to five times during follow-up, via venepuncture at the research institute or finger prick at home, Digital evaluation questionnaire of the finger prick after attempts
- Digital research platform
- Longitudinal
- Remote home finger-prick testing
- Serum samples collected up to five times during follow-up, via venepuncture at the research institute or finger prick at home
- Digital evaluation questionnaire of the finger prick after attempts
Main finding
As reported in the abstract
First finger prick successfully done
Observational data: associations, not effects.
Further findings
Repeated failure
Percent
Aged ≤70 years
93%(95% CI 92%–94%)
Aged >70 years
89%(95% CI 86%–92%)
First finger prick success by sex
- Sex did not impact these success rates
Willingness to perform finger prick
- Both patients and controls were less willing to perform a finger prick for individual healthcare vs scientific research
Original publication
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology. RMD Open. Published 19 April 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →